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centers10–12. Nevertheless, recently available data show 
large numbers of false positive results PET CT scans13–15.
Ultrasound (US) has proven to be a valid, simple, non-
aggressive and relatively cheap method in detecting en-
larged lymph nodes, although the differentiation between 
benign and malignant lymphadenopathy remains to be a 
problem. The size of the node, echogenicity and hilus cir-
culation are important diagnostic signs, and must be in-
cluded on the whole clinical pictures16–18. The method 
heavily depends on the observer. US-guided citopunction 
is a much more reliable method having high sensitivity 
and precision but it is still insufﬁ cient to replace the ex-
tirpation of the node and a pathohistological analysis as a 
»golden standard« in the diagnostics of lymph nodes19–21. 
US-guided citopunction should be sufﬁ cient in most cancer 
patients for diagnostic method, not for therapy and only in 
lymphomas, and rare tumors do we need extirpations for 
diagnostic methods.
The evaluation of enlarged lymph nodes of the neck, 
i.e. the differentiation between benign and malignant 
lymphadenopathies, is of crucial importance in the plan-
ning of treatment of patients with suspect malignancy1–5. 
The available data show that the presence of metastatic 
lymph nodes on one side of the neck reduces a 5-year sur-
vival period by 50%, while the presence of metastatic 
lymph nodes on both sides of the neck reduces the same 
period by 75%3,5. Likewise, lymph nodes on the neck are a 
frequent location of the appearance of lymphomas which 
are difﬁ cult to differentiate from other lymphadenopa-
thies6.
Inspection and palpation of the neck are unreliable7,8, 
while CT and MR show signiﬁ cant limitations in differ-
entiating benign from malignant lymph nodes5,9–11. SPECT 
and PET have made signiﬁ cant clinical inroads in the past 
few years, thanks to new, appropriate radiopharmaceuti-
cals, but they are still beyond the reach of smaller health 
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A B S T R A C T
The study assessed the validity of the lymph node »roundness index« (RI) in the evaluation of enlarged lymph nodes 
of the neck. A total of 107 subjects were included in the prospective study, and 135 enlarged lymph nodes were examined. 
All the subjects were examined clinically and sonographically, the lymph node roundness index was determined, and soon 
after the nodes was surgically removed and pathohistologically diagnosed. On the basis of pathohistological diagnosis 
the study subjects were divided into two groups. The ﬁ rst group consisted of patients with benign lymph nodes, and the 
second one comprised patients with malignant nodes. The second group was further divided into two sub-groups: those 
with primary malignant nodes and those with secondary lymph nodes (metastases). The study showed that the lymph 
node RI statistically differs between the groups. In benign lymphadenopathy the RI was 1.66±0.26, in primary malignant 
lymphadenopathy it was 1.31±0.25 and in secondary malignant lymphadenopathy 1.13±0.11. The analysis demonstrated 
that 82.9% of subjects randomly chosen from the group with primary malignant lymphadenopathy and 94.6% from the 
group with the secondary malignant lymphadenopathy have a smaller RI compared to randomly chosen subjects from 
the group with benign lymphadenopathy. Sensitivity of the method for primary malignant lymphadenopathy was 66.7% 
and speciﬁ city was 92.9%. For secondary malignant lymphadenopathy the sensitivity was 95.5% and speciﬁ city 92.9%. 
Based on this result we can conclude that the lymph node RI is a valid, simple, cost-effective and non-aggressive method 
which may »increase the suspicion« for a benign or malignant lymphadenopathy. RI≤1.5 is indicative of malignant lymph-
adenopathy and RI≥1.5 of benign lymphadenopathy.
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The aim of this study is to assess the validity of the 
lymph node »roundness index« (RI) in the differentiation 
of benign and malignant lymph nodes. The lymph node RI 
is the relationship of the longitudinal and transversal 
cross section of the lymph node, i.e. the relationship of the 
longer and shorter cross section of the lymph node (longi-
tudinal/transverse diameter ratio, L/T)16,22. Literature 
indicates the tendency of malig nantly changed lymph 
nodes towards a round shape (RI≤2), by contrast to a more 
oval shape in benign changes (RI≥2)16,22.
Patients and Methods
The study comprised 107 patients who were sonograph-
ically examined between 2002 and 2009 at the Depart-
ment for ORL of the County Hospital in Livno, BIH and 
the retrospective study comprised 135 lymph nodes which 
were enlarged and manifested various diseases. All the 
nodes were surgically removed from the neck region of 
sonographically examined patients, and pathohistologi-
cally analyzed. Depending on the pathohistological ﬁ nd-
ing, patients were assigned into groups. The ﬁ rst group 
consisted of patients with benign lymph node changes and 
the second group consisted of patients with malignant 
lymph nodes. The second group was further divided into 
two sub-groups: those with primary malignant lymph 
nodes and those with secondary malignant lymph nodes 
(metastases).
Sonographic examination of the neck was done in all 
patients by the »SIEMENS SONOLINE SI-450« ultra-
sound system with a 7.5 MHz short focus probe 6 cm long. 
During the examination longitudinal and transversal 
cross sections of lymph nodes were measured and docu-
mented on the points where the dimensions of the lymph 
nodes were the greatest, and the RI of every lymph node 
was determined. All sonographic examinations and mea-
surements were done by the same physician.
Statistical elaboration of data was done by Statistica 
for Windows, release 8.1 (Stasoft, Inc., Tulsa, OK, USA).
Results
Of the 135 analyzed lymph nodes, 42 were benign: 15 
with a diagnosis of reactively changed node, 9 with chron-
ic inﬂ ammation, 17 with a diagnosis of lymph node TB and 
one with purulent inﬂ ammation. Of the 27 primary ma-
lignant lymph nodes, 5 were diagnosed pathohistologi-
cally as chronic lymphatic leukemia, 17 as non-Hodgkin 
lymphoma and 5 as Hodgkin lymphoma. Of the 66 second-
ary malignant lymph nodes 38 were metastases of plano-
cellular carcinoma, 10 metastases of adenocarcinoma, 7 
metastases of melanoma, 2 metastases of follicular carci-
noma of the thyroid, 5 metastases of papillary carcinoma 
of the thyroid, 1 metastasis of the medullary carcinoma of 
the thyroid, 1 metastasis of anaplastic thyroid carcinoma, 
1 metastasis of epipharyngeal carcinoma and 1 metastasis 
of the sarcoma.
In Table 1 the lymph node RI by patient groups are 
shown.
The RI differs signiﬁ cantly between groups (p<0.001). 
Therefore, a post-hoc analysis was done to determine 
which of the groups differ signiﬁ cantly (Table 2).
Signiﬁ cant differences between the RI of all groups 
were determined (all p<0.001). The subjects with benign 
changes have a signiﬁ cantly greater RI than the subjects 
with primary malignant changes (p<0.001) or subjects 
with secondary malignant changes p<0.001). Subjects 
with primary malignant changes have a signiﬁ cantly 
greater RI than the subjects with secondary malignant 
changes (p<0.001).
The potential of the lymph node RI as a parameter in 
the differentiation of the above groups was evaluated by 
the »receiver operating characteristic« (ROC) analysis.
ROC analysis for primary malignant changes
Table 3 shows the values obtained by ROC analysis for 
the RI of primary malignant tumours.
TABLE 1




X±SD M (5th–95 th) Range 




Primary malignant changes   27 1.31±0.25 1.20 (1.04–1.73) 0.96–2.06
Secondary malignant changes   66 1.13±0.11 1.10 (1.00–1.30) 1.00–1.53
Total 135 1.33±0.31 1.20 (0.96–2.20) 0.96–2.20
TABLE 2
RESULTS OF POST-HOC ANALYSIS FOR THE RI
Tukey HSD test
Approximate Probabilities for Post Hoc Tests
Error: Between MSE= 0.3909, DF=132.00
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Figure 1 shows the ROC curve for the RI of primary 
malignant changes.
Roundness index is a variable with which it is possible 
to differentiate, with statistical signiﬁ cance, benign 
changes from primary malignant changes (p=0.001). By 
means of the ROC analysis it was determined that 82.9% 
of patients randomly chosen from the group with malig-
nant changes will have a smaller RI than the randomly 
chosen patients from the group with benign changes. Be-
cause p<0.001, it means that the area below the curve 
(0.829) is statistically signiﬁ cantly different from 0.5 (the 
diagonal on the ﬁ gure) which supports the conclusion that 
the value of the RI does not statistically signiﬁ cantly dif-
ferentiate the diagnosis made by US from the diagnosis 
made on the basis of pathohistological ﬁ nding.
ROC analysis for secondary malignant changes
Table 4 shows the values obtained by ROC analysis for 
the RI of secondary malignant changes.
Figure 2 shows the ROC curve for the RI of secondary 
malignant changes.
RI is a variable with which it is possible to statisti-
cally signiﬁ cantly differentiate benign changes from sec-
ondary malignant changes (p<0.001). By means of the 
ROC analysis it was determined that 94.6% of subjects 
randomly chosen from the group with secondary malig-
nant changes will have a smaller RI from randomly cho-
sen subjects in the group with benign changes. Because 
p<0.001, it means that the area below the curve (0.946) is 
statistically signiﬁ cantly different from 0.5 (the diagonal 
in the ﬁ gure) which supports the conclusion that the value 
of RI does not statistically signiﬁ cantly differentiate the 
diagnosis made by US from the diagnosis made on the 
basis of pathohistological ﬁ nding.
ROC analysis between primary and secondary 
malignant changes
Table 5 shows the values obtained by ROC analysis 
between primary and secondary malignant changes.
Figure 3 shows the ROC curve for the RI between pri-
mary and secondary malignant changes.
The RI is a variable with which it is possible to statis-
tically signiﬁ cantly differentiate primary malignant 
changes from secondary ones (p<0.001). By means of the 
ROC analysis it was determined that 75.0% of subjects 
randomly chosen from the group with secondary malig-
nant changes will have a smaller RI from randomly cho-
sen subjects from the group with primary changes. Be-
cause p<0.001, it means that the area below the curve 
(0.750) statistically signiﬁ cantly differs from 0.5 (diagonal 
TABLE 3
VALUES OBTAINED BY ROC ANALYSIS FOR THE RI OF 
PRIMARY MALIGNANT CHANGES
Area under the ROC curve 0.829
Standard Error 0.048
95% Conﬁ dence Interval 0.735 to 0.924
Signiﬁ cance level p 0.001
TABLE 4
VALUES OBTAINED BY ROC ANALYSIS FOR THE RI OF 
SECONDARY MALIGNANT CHANGES
Area under the ROC curve 0.946
Standard Error 0.025
95% Conﬁ dence Interval 0.897 to 0.996
Signiﬁ cance level p <0.001
TABLE 5
VALUES OBTAINED BY ROC ANALYSIS FOR THE RI BETWEEN 
PRIMARY AND SECONDARY MALIGNANT CHANGES
Area under the ROC curve 0.750
Standard Error 0.0598
95% Conﬁ dence Interval 0.633 to 0.868
Signiﬁ cance level p <0.001






































Fig. 1. ROC curve for the RI (full line on the basis of measured 
values, dashed line on the basis of theoretical values; rectangle 
describes the sensitivity =66.7%, speciﬁ city =92.9% and criterion 
predictor ≤1.3).
Fig. 2. ROC curve for the RI (full line on the basis of measured 
values, dashed line on the basis of theoretical values; rectangle 
describes sensitivity =95.5%, speciﬁ city =92.9% and criterion pre-
dictor ≤1.3).
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on the ﬁ gure) which supports the conclusion that the val-
ue of RI does not statistically signiﬁ cantly differentiate 
the diagnosis made by US from the diagnosis made on the 
basis of pathohistological ﬁ nding.
Discussion
The differentiation of benign and malignant lymphade-
nopathies is of crucial importance for patients with en-
larged lymph nodes of the neck. It is especially important 
in patients with malignant tumors of head and neck, be-
cause it fundamentally affects prognosis and choice of 
treatment. Likewise, the region of head and neck is a fre-
quent location for the appearance of lymphomas which are 
often difﬁ cult to differentiate from other lymphadenopa-
thies.
With respect to the importance of the evaluation of 
lymph nodes of the neck and with respect to the more or 
less uncertain methods of differentiation between benign 
and malignant lymphadenopaties in current use, all the 
way to surgical extirpation and a pathohistological analy-
sis as a »golden standard«, the paper assesses the validity 
of the lymph node roundness index (RI). Literature sug-
gests the inclination of malignantly changed lymph nodes 
toward the round shape (RI≤2), by contrast to a more oval 
shape in benign lymph node changes (RI≥2)22.
In several published studies different values of the RI 
for malignantly changed lymph nodes appear. Solbiati et 
al. determined that an average RI of 1.5 is characteristic 
of malignant lymph nodes, while the RI above 2 is char-
acteristic for benign lymph nodes18. Similar results were 
obtained by other authors18,20,23–26.
In our study average RI for benign lymph nodes was 
1.66±0.26 (range 1.00–2.20). Of the 42 benign lymph 
nodes, 37 (88%) had a RI greater than 1.5, while for 5 
nodes (12%) the RI was smaller than 1.5. For primary 
malignant lymph nodes the average RI was 1.31±0.25 
(range 0.96–2.06); 24 of the lymph nodes (88.9%) had a RI 
smaller than 1.5. Secondary malignant lymph nodes had 
a RI of 1.13±0.11 (range 1.00–1.53). Of the 66 secondary 
malignant lymph nodes, 63 (95.5%) had a RI smaller than 
1.5. The results in our study are in agreement with the 
previously quoted results from literature, in that the RI 
for malignant lymph nodes was smaller than 1.5 (1.31 and 
1.13)23–26. Benign lymph nodes had a RI smaller than 2, 
but greater than 1.5 (1.66) which contradicts with previ-
ously published studies according to which the lymph node 
RI between 1.5 and 2 can indicate both a benign and ma-
lignant lymphadenopathy18.
A post-hoc analysis showed statistically signiﬁ cant dif-
ferences of the RI between groups, so that the subjects 
with benign lymphadenopathy have a statistically signiﬁ -
cantly greater RI than subjects with malignant lymphade-
nopathy.
The ROC analysis showed that the lymph node RI is a 
variable by which we can statistically signiﬁ cantly dif-
ferentiate benign lymphadenopathy from the malignant 
one. It was proven that 82.9% of subjects randomly chosen 
from the group of primary malignant lymphadenopathies 
and 94.6% of subjects from the group with secondary ma-
lignant lymphadenopathies will have a smaller RI from 
randomly chosen subjects from the group with benign 
lymphadenopathies.
The sensitivity of the method for primary malignant 
lymphadenopathy was 66.7%, and speciﬁ city was 92.9%. 
For secondary malignant lymphadenopathy the sensitiv-
ity was 95.5% and speciﬁ city was 92.9%. High values of 
sensitivity and speciﬁ city of the lymph node RI make it a 
useful modality in the diagnostics of enlarged lymph 
nodes of the neck. The obtained results lead us to conclude 
that a certain value of the RI can help a physician in the 
diagnostics of enlarged lymph nodes of the neck, »increas-
ing the suspicion« that we are dealing with benign or ma-
lignant lymphadenopathies. Together with other available 
methods, in a certain number of cases, it can reduce the 
need for a surgical intervention for diagnostic purposes, 
especially in cases of metastases of malignant tumors.
The determination of the RI is very simple and can be 
done during a sonographic examination which is an eas-
ily accessible, cost-effective, easily repeatable and non-
aggressive method. Algorithms of the diagnostics of en-
larged lymph nodes list the US examination as an initial 
one, after the clinical examination. The determination of 
the RI does not require any additional equipment, and is 
not time-consuming. It is understood that the lymph node 
RI as a modality in the diagnostic procedure of enlarged 
lymph nodes cannot be a replacement for cytological punc-
ture controlled by ultrasound or biopsy with a pathohisto-
logical diagnosis as a »golden standard«, but it can »in-
crease the suspicion« in benign or malignant 
lymphadenopathy and in a certain number of cases avoid 
the need for surgery – the biopsy of the lymph node.
On the basis of results of this study we can conclude 
that the lymph node RI smaller than 1.5 (RI≤1.5) speaks 
in favor of malignant lymphadenopathy, whereas the 
lymph node RI greater than 1.5 (RI≥1.5) speaks in favor 
of benign lymphadenopathy. Therefore, we feel free to as-
sert that the determination of lymph node RI should be 
included in the algorithms of diagnostics of enlarged 
lymph nodes of the neck.



















Fig. 3. ROC curve for the RI (full line on the basis of measured 
values, dashed line on the basis of theoretical values; rectangle 
describes sensitivity =53.0%, speciﬁ city =85.2 and criterion pre-
dictor ≤1.12).
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INDEKS ZAOKRUŽENOSTI LIMFNIH ČVOROVA U EVALUACIJI LIMFNIH ČVOROVA NA VRATU
S A Ž E T A K
U istraživanju je procijenjena valjanost indeksa zaokruženosti limfnog čvora (engl. Roundness indeks, RI, Solbiati 
indeks) u evaluaciji uvećanih limfnih čvorova vrata. Istraživanjem je obuhvaćeno 107 pacijenata, a prospektivna studi-
ja je uključila 135 uvećanih limfnih čvorova. Svi pacijenti su klinički pregledani, ultrazvučno pregledani te im je određen 
indeks zaokruženosti limfnih čvorova a potom su u kraćem vremenskom razdoblju čvorovi kirurški odstranjeni i 
patohistološki dijagnosticirani. Temeljem patohistološke dijagnoze ispitanici su podijeljeni u dvije skupine. Prvu skupinu 
su činili bolesnici s benignim limfnim čvorovima a drugu skupinu bolesnici s malignim limfnim čvorovima. Druga 
skupina je podijeljena u dvije podskupine; primarni maligni čvorovi i sekundarni limfni čvorovi (presadnice). Istraživanje 
je pokazalo da se indeks zaokruženosti limfnog čvora (RI) statistički značajno razlikuje između skupina. RI za benigne 
limfadenopatije je bio 1,66±0,26, za primarne maligne limfadenopatije 1,31±0,25 te 1,13±0,11 za sekundarne limfade-
nopatije. Analizom je ustvrđeno da će 82,9% ispitanika slučajno odabranih iz skupine s primarnim malignim limfade-
nopatijama i 94,6% iz skupine sa sekundarnim malignim limfadenopatijama imati manji RI od slučano odabranih 
ispitanika iz skupine s benignim limfadenopatijama. Osjetljivost metoda za primarne maligne limfadenopatije bila je 
66,7% a speciﬁ čnost 92,9%. Za sekundarne maligne limfadenopatije osjetljivost je iznosila 95,5% a speciﬁ čnost 92,9%. 
Temeljem rezultata ovoga istraživanja možemo zaključiti da je indeks zaokruženost limfnog čvora valjana, jednostavna, 
jeftina i neagresivna metoda koja može »povećati sumnju« u benignu ili malignu limfadenopatiju. RI≤1,5 govori u prilog 
malignih limfadenopatija a RI≥1,5 za benigne limfadenopatije.
